omega-n-methylarginine has been researched along with thromboxanes in 4 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 3,202 | 149 | 199 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mayhan, WG; Sharpe, GM; Simmons, LK | 1 |
Mayhan, WG | 1 |
Affolter, JT; Balment, RJ; Boyd, J; de Haas, SL; Pellegrini, MP; Webb, DJ; Wilkinson, IB; Winter, MJ | 1 |
Engeli, S; Jordan, J; Stichtenoth, DO; Tank, J; Tsikas, D | 1 |
1 trial(s) available for omega-n-methylarginine and thromboxanes
Article | Year |
---|---|
High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.
Topics: Adult; Analysis of Variance; Aspirin; Blood Pressure; Carrier Proteins; Enzyme Inhibitors; Epoprostenol; Forearm; Hand; Humans; Infusions, Intra-Arterial; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Peptides; Pilot Projects; Plethysmography; Regional Blood Flow; Thromboxanes; Urotensins; Vasoconstrictor Agents; Veins | 2002 |
3 other study(ies) available for omega-n-methylarginine and thromboxanes
Article | Year |
---|---|
Mechanism of impaired responses of cerebral arterioles during diabetes mellitus.
Topics: Animals; Arginine; Arterioles; Brain; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Experimental; Fatty Acids, Unsaturated; Hydrazines; Indomethacin; Nitric Oxide; omega-N-Methylarginine; Prostaglandins H; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxanes; Vasoconstriction; Vasodilation | 1991 |
Constrictor responses of the rat basilar artery during diabetes mellitus.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Comment on: Ott et al. Reduction in basal nitric oxide activity causes albuminuria. Diabetes 2011;60:572-576.
Topics: Albuminuria; Animals; Humans; Kidney; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Thromboxanes | 2011 |